These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15808191)

  • 41. Choroidal neovascularization in pathologic myopia: three-year results after photodynamic therapy.
    Krebs I; Binder S; Stolba U; Glittenberg C; Brannath W; Goll A
    Am J Ophthalmol; 2005 Sep; 140(3):416-25. PubMed ID: 16139000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Verteporfin and photosensitivity in diabetic].
    Asensio Sánchez VM; Corral Azor A; García Pascual A
    Arch Soc Esp Oftalmol; 2003 May; 78(5):277-9. PubMed ID: 12789632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [New methods of treatment of age-related macular degeneration. Photodynamic therapy. Part I].
    Gierek-Łapińska A; Wykrota H; Trzciakowski K
    Klin Oczna; 2002; 104(3-4):276-82. PubMed ID: 12608319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration.
    Slakter JS; Bochow TW; D'Amico DJ; Marks B; Jerdan J; Sullivan EK; Robertson SM; Slakter JS; Sullins G; Zilliox P;
    Ophthalmology; 2006 Jan; 113(1):3-13. PubMed ID: 16368146
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.
    Heier JS; Boyer DS; Ciulla TA; Ferrone PJ; Jumper JM; Gentile RC; Kotlovker D; Chung CY; Kim RY;
    Arch Ophthalmol; 2006 Nov; 124(11):1532-42. PubMed ID: 17101999
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.
    Husain D; Kramer M; Kenny AG; Michaud N; Flotte TJ; Gragoudas ES; Miller JW
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2322-31. PubMed ID: 10476799
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bilateral punctal-canalicular stenosis following photodynamic therapy for choroidal neovascularization.
    Yim JF; Crofts KP
    Cutan Ocul Toxicol; 2011 Mar; 30(1):78-9. PubMed ID: 20950246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Results of photodynamic treatment of choroidal neovascular membrane in age-related macular degeneration].
    Dubská Z; Kalvodová B
    Cas Lek Cesk; 2006; 145(10):800, 802-3. PubMed ID: 17121073
    [No Abstract]   [Full Text] [Related]  

  • 50. Central and peripheral vision loss associated with nefazodone usage.
    Luu C; Kiely P; Crewther D; Kowal L; Crewther S
    Doc Ophthalmol; 2003 May; 106(3):319-25. PubMed ID: 12737510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute respiratory distress due to verteporfin infusion for photodynamic therapy.
    Fossarello M; Peiretti E
    Arch Ophthalmol; 2006 Oct; 124(10):1509-10. PubMed ID: 17030732
    [No Abstract]   [Full Text] [Related]  

  • 52. Optical coherence tomography findings in nicotinic acid maculopathy.
    Spirn MJ; Warren FA; Guyer DR; Klancnik JM; Spaide RF
    Am J Ophthalmol; 2003 Jun; 135(6):913-4. PubMed ID: 12788145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Photodynamic therapy.
    Kotoula MG; Tsironi EE; Karabatsas CH; Chatzoulis DZ
    Retina; 2005 Jan; 25(1):102-3. PubMed ID: 15655455
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical Phenotypes of Poppers Maculopathy and Their Links to Visual and Anatomic Recovery.
    Van Bol LB; Kurt RA; Keane PA; Pal B; Sivaprasad S
    Ophthalmology; 2017 Sep; 124(9):1425-1427. PubMed ID: 28648381
    [No Abstract]   [Full Text] [Related]  

  • 55. Bilateral Severe Decreased Vision With Normal Examination Findings.
    Rayess N; Patel VR
    JAMA Ophthalmol; 2018 Oct; 136(10):1201-1202. PubMed ID: 30073263
    [No Abstract]   [Full Text] [Related]  

  • 56. Diagnostic and therapeutic challenges. Progressive bilateral visual loss over the last seven years.
    Drenser KA; Williams GA; Fu AD; Egan C; Hykin PG; Dugel PU; Rao PK
    Retina; 2005 Sep; 25(6):778-83. PubMed ID: 16141868
    [No Abstract]   [Full Text] [Related]  

  • 57. Acute visual loss caused by transient choroid ischemia and subretinal hyperreflective material after photodynamic therapy.
    Chen YC; Chen SN; Chuang CC
    J Formos Med Assoc; 2020 Sep; 119(9):1448-1449. PubMed ID: 32165088
    [No Abstract]   [Full Text] [Related]  

  • 58. Accidental pregnancy exposure to verteporfin: obstetrical and neonatal outcomes: a case report.
    Rodrigues M; Meira D; Batista S; Carrilho MM
    Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):236-7. PubMed ID: 19432621
    [No Abstract]   [Full Text] [Related]  

  • 59. Photodynamic therapy for focal RPE leaks.
    Koh AH
    Ophthalmology; 2006 Nov; 113(11):2110.e1-3; author reply 2111. PubMed ID: 17074572
    [No Abstract]   [Full Text] [Related]  

  • 60. Hydroxychloroquine: A Brief Review on Screening, Toxicity, and Progression.
    Modi YS; Singh RP; Fine HF
    Ophthalmic Surg Lasers Imaging Retina; 2016 Mar; 47(3):207-17. PubMed ID: 26985794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.